ICUI ICU Medical, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$159,38
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$112,5052 haftanın en düşüğü
$192,8552 haftanın en yükseği
Piyasa Değeri (MRQ)
$3.99B
P/E (TTM)
133.9
Hisse Başına Kâr (TTM)
$1.19
Gelir (TTM)
$2.16B
rozetleriniz
52 Haftlık Aralık
$112–$193
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$193
P/E
133.9
ROE
1.4%
Net Kâr Marjı
1.4%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ICUI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$159.38
Piyasa Değeri (MRQ)
$3.99B
P/E (TTM)
133.9
Hisse Başına Kâr (TTM)
$1.19
Gelir (TTM)
$2.16B
ROE (TTM)
1.4%
D/E Borç/Özsermaye (MRQ)
0.6
52 Haftlık Aralık
$113–$193
ICUI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 18 Mart 2002 | 3-for-2 | İleri |
| 01 Nisan 1993 | 3-for-2 | İleri |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$2.23B2016-12-31 → 2025-12-31
Hisse Başına Kâr$0.032016-12-31 → 2025-12-31
Serbest Nakit Akışı$92M2016-12-31 → 2025-12-31
Net kar marjı1.4%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ICUI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 133.95Y ort. ≈928.4 | ≈928.4 | 28.6 | Aşırı değerli | |
| F/S (TTM) | 1.85Y ort. ≈2.0 | ≈2.0 | 2.6 | Düşük değerli | |
| F/D (MRQ) | 1.95Y ort. ≈2.0 | ≈2.0 | 2.5 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 26.15Y ort. ≈30.9 | ≈30.9 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 16.95Y ort. ≈17.9 | ≈17.9 | 17.6 | Aşırı değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 2.5 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ICUI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 39.1%5Y ort. ≈34.4% | ≈34.4% | 55.0% | Zayıf | |
| Faaliyet Kâr Marjı (TTM) | 3.3%5Y ort. ≈2.4% | ≈2.4% | 11.6% | Zayıf | |
| FAVÖK Marjı (TTM) | 12.7%5Y ort. ≈11.5% | ≈11.5% | 14.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 0.03% | · | 10.9% | Zayıf | |
| Net Kâr Marjı (TTM) | 1.4%5Y ort. ≈-0.33% | ≈-0.33% | 8.9% | Zayıf | |
| ROA (TTM) | 0.74%5Y ort. ≈-0.01% | ≈-0.01% | 1.6% | Ortalamanın altında | |
| ROE (TTM) | 1.4%5Y ort. ≈-0.87% | ≈-0.87% | 4.2% | Ortalamanın altında | |
| ROIC | 0.55% | · | 3.2% | Ortalamanın altında |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ICUI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.65Y ort. ≈0.7 | ≈0.7 | 0.5 | Aynı seviyede | |
| Cari Oran (MRQ) | 2.45Y ort. ≈3.0 | ≈3.0 | 3.0 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.45Y ort. ≈1.3 | ≈1.3 | 1.6 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.65Y ort. ≈0.7 | ≈0.7 | 0.6 | Aynı seviyede | |
| Interest Coverage (Faiz Karşılama Oranı) | 0.55Y ort. ≈28.8 | ≈28.8 | 4.2 | Ortalamanın altında |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ICUI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -6.3%5Y ort. ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -0.72%5Y ort. ≈14.1% | ≈14.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 11.9% | · | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -62.5% | · | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -61.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ICUI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.55Y ort. ≈0.6 | ≈0.6 | 0.6 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 2.35Y ort. ≈2.6 | ≈2.6 | 2.8 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 12.35Y ort. ≈12.7 | ≈12.7 | 6.4 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$171.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
25.0%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $2.37 | $1.95 | 21.4% |
| 31 Mart 2026 | $1.97 | $1.79 | 10.3% | |
| 31 Aralık 2025 | $1.91 | $1.73 | 10.7% | |
| 30 Eylül 2025 | $2.03 | $1.46 | 38.9% | |
| 30 Haziran 2025 | $2.10 | $1.53 | 37.3% | |
| 31 Mart 2025 | $1.72 | $1.31 | 31.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Cost of Revenue | $1.41B | $1.56B | $1.52B | $1.58B | $825M | $810M | $794M | $830M | $867M | $178M | $161M | $158M | |
| Gross Profit | $822M | $825M | $740M | $698M | $491M | $461M | $472M | $570M | $426M | $201M | $181M | $151M | |
| R&D Expense | $87M | $89M | $85M | $93M | $47M | $43M | $49M | $53M | $51M | $13M | $16M | $18M | |
| SG&A Expense | $625M | $639M | $607M | $608M | $303M | $284M | $277M | $320M | $302M | $89M | $83M | $89M | |
| Operating Expenses | $779M | $782M | $717M | $741M | $368M | $363M | $365M | $540M | $439M | $118M | $112M | $112M | |
| Operating Income | $43M | $43M | $23M | $-43M | $123M | $98M | $107M | $30M | $-13M | $83M | $69M | $39M | |
| Interest Expense | $93M | $107M | $103M | $71M | $858.0K | $2M | $549.0K | $709.0K | $2M | $118.0K | $39.0K | · | |
| Other Non-op | $-232.0K | $-13M | $-6M | $-5M | $-2M | $-3M | $8M | $-7M | $-4M | $885.0K | $1M | $755.0K | |
| Pretax Income | $4M | $-66M | $-78M | · | · | $97M | $115M | $22M | $51M | $85M | $70M | $40M | |
| Income Tax | $2M | $52M | $-49M | $-40M | $20M | $11M | $14M | $-6M | $-17M | $22M | $25M | $13M | |
| Net Income | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| EPS (Basic) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 | $4.16 | $4.90 | $1.41 | $3.50 | $3.90 | $2.84 | $1.72 | |
| EPS (Diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 | |
| Shares (Basic) | 24,640,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,206,000 | 20,907,000 | 20,629,000 | 20,394,000 | 19,614,000 | 16,168,000 | 15,848,000 | 15,282,000 | |
| Shares (Diluted) | 24,904,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,781,000 | 21,591,000 | 21,545,000 | 21,601,000 | 20,858,000 | 17,254,000 | 16,496,000 | 15,647,000 | |
| EBITDA | $244M | $262M | $252M | $192M | $213M | $184M | $184M | $96M | $51M | $102M | $87M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $309M | $255M | $213M | $553M | $396M | $269M | $345M | $290M | $445M | $336M | $276M | |
| Short-term Investments | · | · | · | · | · | $15M | $24M | $37M | $10M | $0 | $41M | $71M | |
| Receivables | $181M | $183M | $162M | $222M | $106M | $124M | $202M | $176M | $113M | $56M | $58M | $39M | |
| Inventory | $616M | $585M | $709M | $696M | $290M | $315M | $338M | $311M | $289M | $49M | $44M | $37M | |
| Prepaid Expense | $86M | $82M | $74M | $89M | $47M | $41M | $34M | $46M | $41M | $7M | $8M | $6M | |
| Other Current Assets | $26M | $23M | $4M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Current Assets | $1.19B | $1.44B | $1.22B | $1.24B | $1.03B | $921M | $882M | $927M | $865M | $569M | $505M | $433M | |
| PP&E (Net) | $452M | $443M | $613M | $636M | $468M | $467M | $456M | $433M | $399M | $86M | $74M | $86M | |
| PP&E (Gross) | $1.10B | $1.04B | $1.24B | $1.16B | $905M | $843M | $776M | $695M | $609M | $244M | $223M | $225M | |
| Accum. Depreciation | $646M | $593M | $624M | $526M | $437M | $376M | $320M | $262M | $210M | $158M | $149M | $139M | |
| Goodwill | $1.50B | $1.43B | $1.47B | $1.45B | $43M | $33M | $31M | $11M | $12M | $6M | $6M | $1M | |
| Intangibles | $634M | $741M | $871M | $983M | $188M | $197M | $211M | $133M | $144M | $22M | $24M | $7M | |
| Other Non-current Assets | $63M | $65M | $94M | $105M | $64M | $55M | $49M | $40M | $38M | $0 | · | · | |
| Total Assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Accounts Payable | $154M | $148M | $150M | $216M | $81M | $72M | $129M | $120M | $78M | $15M | $14M | $11M | |
| Accrued Liabilities | $315M | $307M | $268M | $243M | $118M | $97M | $118M | $129M | $132M | $26M | $29M | $17M | |
| Current Liabilities | $499M | $556M | $482M | $495M | $201M | $195M | $248M | $249M | $210M | $41M | $43M | $29M | |
| Capital Leases | $44M | $41M | $53M | $61M | $34M | $41M | $29M | $0 | $0 | · | · | · | |
| Deferred Tax | $38M | $49M | $56M | $126M | $1M | $2M | $2M | $721.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | $90M | $67M | $100M | $114M | $42M | $48M | $33M | · | · | · | · | · | |
| Long-term Debt | $1.28B | $1.58B | $1.63B | $1.65B | $0 | · | · | · | · | · | · | · | |
| Total Debt | $1.28B | $1.58B | $1.63B | $1.65B | · | · | · | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $691M | $690M | $808M | $838M | $912M | $809M | $722M | $621M | $586M | $517M | $454M | $409M | |
| Treasury Stock | $22.0K | $92.0K | $262.0K | $243.0K | $27.0K | $39.0K | $157.0K | $95.0K | $0 | $14.0K | $0 | $0 | |
| AOCI | $-35M | $-139M | $-53M | $-81M | $-19M | $-2M | $-15M | $-17M | $-15M | $-21M | $-21M | $-10M | |
| Stockholders' Equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660M | $580M | $508M | |
| Liabilities + Equity | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Shares Outstanding | 24,688,000 | 24,517,000 | 24,141,000 | 23,993,000 | 21,280,000 | 21,058,000 | 20,742,000 | 20,491,229 | 20,210,054 | 16,337,670 | 16,086,000 | 15,595,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $201M | $220M | $229M | $235M | $90M | $86M | $77M | $75M | $67M | $19M | $18M | $19M | |
| Stock-based Comp | $56M | $47M | $41M | $36M | $27M | $24M | $22M | $24M | $19M | $15M | $13M | $10M | |
| Deferred Tax | $-14M | $6M | $-70M | $-61M | $-11M | $-5M | $-4M | $-18M | $-26M | $-3M | $4M | $-1M | |
| Amort. of Intangibles | $131M | $134M | $132M | $139M | $24M | $23M | $18M | $17M | $15M | $3M | $2M | $2M | |
| Restructuring | · | · | $6M | $10M | $-2M | $8M | $8M | $4M | $19M | $800.0K | $7M | $4M | |
| Other Non-cash | $-64M | $50M | $-2M | $-198M | $59M | $31M | $-94M | $50M | $25M | $-5M | $-25M | · | |
| Operating Cash Flow | $180M | $204M | $166M | $-62M | $268M | $223M | $102M | $160M | $154M | $90M | $64M | $66M | |
| CapEx | $88M | $79M | $84M | $90M | $69M | $92M | $97M | $93M | $74M | $23M | $13M | $17M | |
| Investing Cash Flow | $122M | $-89M | $-88M | $-1.91B | $-91M | $-98M | $-167M | $-103M | $-267M | $16M | $-11M | $-22M | |
| Net Debt Issued | $-303M | $-51M | $-30M | $-22M | $0 | $-150M | $0 | $0 | $-75M | · | · | · | |
| Stock Repurchased | $9M | $12M | $9M | $11M | $8M | $13M | $19M | $6M | $4M | $17M | $2M | $6M | |
| Net Stock Activity | $-9M | $-12M | $-9M | $-11M | $-8M | $-13M | $-19M | $-6M | $-4M | $-17M | $-2M | · | |
| Financing Cash Flow | $-312M | $-56M | $-36M | $1.64B | $-17M | $-40.0K | $-11M | $8M | $-44M | $2M | $16M | $14M | |
| Net Change in Cash | $-603.0K | $54M | $45M | $-344M | $157M | $127M | $-76M | $55M | $-155M | $109M | $60M | $50M | |
| Free Cash Flow | $92M | $125M | $82M | $-152M | $199M | $131M | $5M | $67M | $80M | $67M | $42M | · | |
| Levered FCF | $51M | · | · | · | · | $129M | $4M | $67M | $77M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% | 52.9% | · | |
| Operating Margin | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 1.5% | -1.2% | 21.9% | 20.1% | · | |
| Net Margin | 0.03% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% | 13.2% | · | |
| Pretax Margin | 0.20% | · | · | · | · | 7.7% | 9.1% | 1.6% | 4.0% | 22.4% | 20.4% | · | |
| EBITDA Margin | 10.9% | 11.0% | 11.1% | 8.4% | 16.2% | 14.5% | 14.5% | 6.9% | 4.0% | 26.9% | 25.4% | · | |
| ROA | 0.02% | -2.7% | -0.67% | -2.3% | 5.7% | 5.0% | 6.2% | 1.9% | 6.2% | 9.5% | 7.7% | · | |
| ROE | 0.03% | -5.9% | -1.4% | -3.5% | 6.4% | 5.9% | 7.4% | 2.3% | 7.4% | 10.2% | 8.3% | · | |
| ROIC | 0.55% | · | · | · | · | 5.8% | 6.9% | 2.2% | -1.7% | 9.3% | 7.6% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 | 4.7 | 3.6 | 3.7 | 4.1 | 14.0 | 11.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 | 2.7 | 2.0 | 2.2 | 2.0 | 12.4 | 10.2 | · | |
| Debt / Equity | 0.6 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.8 | 0.7 | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | 0.5 | 0.4 | 0.2 | -0.6 | 143.6 | 56.0 | 195.6 | 30.5 | -7.4 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.3 | 2.4 | 2.2 | 3.2 | 2.7 | 2.5 | 2.4 | 2.8 | 3.0 | 3.8 | 4.0 | · | |
| Receivables Turnover | 12.3 | 13.8 | 11.8 | 13.9 | 11.4 | 7.8 | 6.7 | 9.7 | 15.3 | 6.7 | 7.1 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.03 | $80.16 | $87.96 | · | $75.94 | $71.34 | $66.40 | $61.67 | $59.29 | $40.41 | $36.05 | · | |
| Revenue / Share | $89.59 | $97.67 | $93.77 | $95.53 | $60.43 | $58.87 | $58.77 | $64.81 | $61.97 | $21.99 | $20.71 | · | |
| Cash Flow / Share | $7.22 | $8.37 | $6.90 | $-2.60 | $12.28 | $10.32 | $4.73 | $7.42 | $7.40 | $5.21 | $3.33 | · | |
| Cash / Share | · | $12.59 | $10.55 | · | $25.98 | $18.81 | $12.95 | $16.83 | $14.35 | $27.24 | $20.90 | · | |
| EPS (TTM) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -6.3% | 5.4% | -0.92% | 73.2% | 3.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.72% | 21.9% | 21.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 17.9% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -62.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 18.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -61.5% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Net Income TTM | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| Market Cap | $3.52B | $3.80B | $2.41B | · | $5.05B | $4.52B | $3.88B | $4.71B | $4.37B | $2.41B | $1.81B | · | |
| Enterprise Value | · | $5.08B | $3.78B | · | · | · | · | · | · | · | · | · | |
| P/E | 4755.7 | -32.1 | -81.1 | -50.6 | 50.1 | 53.4 | 39.9 | 172.7 | 65.7 | 40.3 | 41.3 | 48.8 | |
| P/S | 1.6 | 1.6 | 1.1 | · | 3.8 | 3.6 | 3.1 | 3.4 | 3.4 | 6.3 | 5.3 | · | |
| P/B | 1.7 | 1.9 | 1.1 | · | 3.1 | 3.0 | 2.8 | 3.7 | 3.6 | 3.6 | 3.1 | · | |
| P / Tangible Book | · | · | · | · | 3.6 | 3.6 | · | · | · | · | · | · | |
| P / Cash Flow | 19.6 | 18.6 | 14.5 | · | 18.9 | 20.3 | 38.1 | 29.4 | 28.3 | 26.8 | 33.1 | · | |
| P / FCF | 38.4 | 30.5 | 29.3 | · | 25.4 | 34.5 | 842.7 | 69.7 | 54.6 | 36.2 | 43.3 | · | |
| EV / EBITDA | · | 19.3 | 15.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | 40.7 | 45.9 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 2.1 | 1.7 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.02% | -3.1% | -1.2% | -2.0% | 2.0% | 1.9% | 2.5% | 0.58% | 1.5% | 2.5% | 2.4% | 2.1% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $552M | $530M | $541M | $537M | $549M | $605M | $630M | $589M | $596M | $567M | $588M | $553M | $549M | $569M | $578M | $598M | |
| Cost of Revenue | $317M | $324M | $338M | $336M | $341M | $395M | $403M | $384M | $389M | $381M | $416M | $369M | $357M | $377M | $403M | $411M | |
| Gross Profit | $235M | $206M | $203M | $201M | $208M | $210M | $227M | $205M | $207M | $185M | $172M | $184M | $192M | $192M | $175M | $186M | |
| R&D Expense | $23M | $21M | $21M | $21M | $22M | $23M | $22M | $21M | $23M | $22M | $22M | $21M | $22M | $20M | $23M | $23M | |
| SG&A Expense | $152M | $155M | $156M | $153M | $159M | $157M | $159M | $163M | $160M | $158M | $155M | $149M | $151M | $153M | $143M | $153M | |
| Operating Expenses | $196M | $193M | $197M | $187M | $197M | $197M | $190M | $197M | $200M | $196M | $184M | $161M | $190M | $183M | $175M | $187M | |
| Operating Income | $39M | $14M | $6M | $14M | $11M | $13M | $38M | $8M | $8M | $-11M | $-12M | $23M | $3M | $9M | $-222.0K | $-467.0K | |
| Interest Expense | $16M | $16M | $31M | $20M | $21M | $22M | $34M | $25M | $24M | $24M | $32M | $24M | $24M | $23M | $25M | $18M | |
| Other Non-op | $-236.0K | $-1M | $-894.0K | $607.0K | $2M | $-2M | $-6M | $-1M | $-3M | $-2M | $-90.0K | $-4M | $-2M | $-269.0K | $-1M | $-3M | |
| Pretax Income | $23M | $-4M | $-16M | $-3M | $34M | $-11M | $8M | $-18M | $-20M | $-37M | $-37M | $-5M | $-23M | $-13M | · | $-21M | |
| Income Tax | $7M | $-35M | $-3M | $-658.0K | $1M | $5M | $32M | $15M | $2M | $3M | $-20M | $-13M | $-13M | $-4M | $-6M | $-8M | |
| Net Income | $19M | $30M | $-16M | $-3M | $35M | $-15M | $-24M | $-33M | $-21M | $-39M | $-17M | $7M | $-10M | $-10M | $-19M | $-10M | |
| EPS (Basic) | $0.76 | $1.22 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| EPS (Diluted) | $0.76 | $1.20 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| Shares (Basic) | 25,000,000 | 24,764,000 | · | 24,686,000 | 24,645,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,132,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| Shares (Diluted) | 25,044,000 | 25,182,000 | · | 24,686,000 | 24,708,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,368,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| EBITDA | $39M | $64M | · | $14M | $11M | $62M | · | $8M | $8M | $45M | · | $23M | $3M | $65M | · | $-467.0K |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $313M | $303M | $251M | · | $199M | $198M | $224M | · | $247M | |
| Receivables | $184M | $201M | $181M | $192M | $179M | $171M | $183M | $174M | $152M | $145M | · | $162M | $162M | $139M | · | $213M | |
| Inventory | $607M | $606M | $616M | $622M | $616M | $590M | $585M | $692M | $683M | $693M | · | $760M | $775M | $748M | · | $625M | |
| Prepaid Expense | $122M | $118M | $86M | $94M | $84M | $75M | $82M | $74M | $81M | $83M | · | $84M | $96M | $87M | · | $94M | |
| Other Current Assets | $34M | $39M | $20M | $23M | $23M | $6M | $23M | $5M | $5M | $4M | · | $3M | $3M | $4M | · | $3M | |
| Current Assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B | $1.19B | · | $1.22B | $1.24B | $1.21B | · | $1.20B | |
| PP&E (Net) | $447M | $445M | $452M | $456M | $452M | $442M | $443M | $596M | $594M | $603M | · | $609M | $617M | $624M | · | $656M | |
| PP&E (Gross) | $1.12B | $1.11B | $1.10B | $1.09B | $1.08B | $1.05B | $1.04B | $1.28B | $1.26B | $1.25B | · | $1.21B | $1.19B | $1.17B | · | $1.15B | |
| Accum. Depreciation | $676M | $661M | $646M | $636M | $630M | $608M | $593M | $685M | $664M | $644M | · | $597M | $575M | $550M | · | $498M | |
| Goodwill | $1.48B | $1.49B | $1.50B | $1.50B | $1.50B | $1.46B | $1.43B | $1.48B | $1.45B | $1.46B | $1.47B | $1.44B | $1.46B | $1.46B | $1.45B | $1.37B | |
| Intangibles | $568M | $599M | $634M | $665M | $698M | $717M | $741M | $786M | $806M | $837M | · | $891M | $930M | $958M | · | $1.02B | |
| Other Non-current Assets | $63M | $63M | $63M | $61M | $61M | $65M | $65M | $87M | $95M | $97M | · | $108M | $100M | $102M | · | $111M | |
| Total Assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Accounts Payable | $149M | $174M | $154M | $172M | $169M | $180M | $148M | $169M | $156M | $152M | · | $149M | $167M | $186M | · | $205M | |
| Accrued Liabilities | $322M | $315M | $315M | $316M | $314M | $279M | $307M | $326M | $300M | $248M | · | $251M | $255M | $235M | · | $244M | |
| Current Liabilities | $498M | $518M | $499M | $493M | $483M | $549M | $556M | $550M | $512M | $455M | · | $464M | $484M | $462M | · | $489M | |
| Capital Leases | $37M | $41M | $44M | $47M | $49M | $48M | $41M | $45M | $52M | $50M | · | $57M | $60M | $63M | · | $63M | |
| Deferred Tax | $12M | $15M | $38M | $41M | $43M | $45M | $49M | $49M | $54M | $56M | · | $78M | $90M | $115M | · | $154M | |
| Other Non-current Liabilities | $71M | $82M | · | $94M | $96M | $78M | · | $80M | $91M | $103M | · | $100M | $110M | $114M | · | $119M | |
| Long-term Debt | $1.23B | $1.28B | $1.28B | $1.31B | $1.34B | $1.54B | $1.58B | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Total Debt | $1.23B | $1.28B | · | $1.31B | $1.34B | $1.54B | · | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $740M | $721M | $691M | $707M | $710M | $675M | $690M | $714M | $747M | $768M | · | $825M | $818M | $828M | · | $853M | |
| Treasury Stock | $23M | $25M | $22.0K | $12.0K | $6.0K | $60.0K | $92.0K | $208.0K | $518.0K | $5M | · | $672.0K | $2M | $8M | · | $126.0K | |
| AOCI | $-43M | $-52M | $-35M | $-33M | $-33M | $-105M | $-139M | $-62M | $-92M | $-70M | $-53M | $-85M | $-49M | $-62M | $-81M | $-166M | |
| Stockholders' Equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B | · | $2.12B | $2.10B | $2.11B | $2.10B | $2.09B | $2.01B | |
| Liabilities + Equity | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Shares Outstanding | 25,007,000 | 24,993,000 | 24,688,000 | 24,686,000 | 24,685,000 | 24,611,000 | 24,517,000 | 24,459,000 | 24,425,000 | 24,365,000 | · | 24,139,000 | 24,104,000 | 24,064,000 | · | 23,979,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $50M | $50M | $51M | $51M | $50M | $49M | $53M | $56M | $55M | $56M | $57M | $58M | $58M | $56M | $57M | $59M | |
| Stock-based Comp | $12M | $14M | $14M | $15M | $14M | $12M | $13M | $12M | $11M | $12M | $11M | $11M | $10M | $9M | $7M | $9M | |
| Amort. of Intangibles | $33M | $33M | $33M | $33M | $33M | $33M | $34M | $34M | $33M | $33M | $33M | $33M | $33M | $32M | $30M | $36M | |
| Restructuring | $7M | $7M | · | $6M | $8M | $7M | · | $4M | $8M | $5M | · | $1M | $1M | $3M | · | $2M | |
| Other Non-cash | · | $-55M | · | · | · | $5M | · | · | · | · | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $80M | $39M | $61M | $57M | $11M | $51M | $40M | $36M | $82M | $46M | $91M | $35M | $-1M | $41M | $-2M | $2M | |
| CapEx | $19M | $11M | $25M | $29M | $20M | $15M | $24M | $20M | $19M | $16M | $30M | $21M | $18M | $14M | $22M | $21M | |
| Investing Cash Flow | $-20M | $-11M | $-18M | $-30M | $187M | $-17M | $-27M | $-23M | $-22M | $-18M | $-31M | $-25M | $-18M | $-15M | $-24M | $-13M | |
| Net Debt Issued | · | $-5M | · | · | · | $-48M | · | · | · | $-13M | · | · | · | $-7M | · | · | |
| Financing Cash Flow | $-50M | $-44M | $-34M | $-26M | $-195M | $-56M | $-8M | $-10M | $-10M | $-27M | $-8M | $-6M | $-6M | $-16M | $-10M | $3M | |
| Net Change in Cash | $10M | $-20M | $8M | $-293.0K | $10M | $-19M | $-4M | $10M | $51M | $-3M | $57M | $1M | $-25M | $12M | $-35M | $-12M | |
| Free Cash Flow | · | $28M | · | · | · | $37M | · | · | · | $30M | · | · | · | $27M | · | · | |
| Levered FCF | · | $155M | · | · | · | $5M | · | · | · | $4M | · | · | · | $11M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.6% | 38.9% | · | 37.4% | 37.9% | 34.8% | · | 34.8% | 34.8% | 32.7% | · | 33.2% | 35.0% | 33.8% | · | 31.2% | |
| Operating Margin | 7.1% | 2.6% | · | 2.5% | 1.9% | 2.1% | · | 1.4% | 1.3% | -1.9% | · | 4.1% | 0.50% | 1.7% | · | -0.08% | |
| Net Margin | 3.5% | 5.7% | · | -0.63% | 6.4% | -2.6% | · | -5.6% | -3.6% | · | · | 1.3% | -1.8% | -1.7% | · | -2.2% | |
| Pretax Margin | 4.2% | -0.75% | · | -0.47% | 6.1% | -1.8% | · | -3.0% | -3.3% | -6.5% | · | -0.97% | -4.2% | -2.4% | · | -3.6% | |
| EBITDA Margin | 7.1% | 12.0% | · | 2.5% | 1.9% | 10.3% | · | 1.4% | 1.3% | 7.9% | · | 4.1% | 0.50% | 11.5% | · | -0.08% | |
| ROA | 0.47% | 0.74% | · | -0.08% | 0.84% | -0.37% | · | -0.76% | -0.49% | · | · | 0.16% | -0.22% | -0.21% | · | -0.42% | |
| ROE | 0.89% | 1.5% | · | -0.16% | 1.7% | -0.76% | · | -1.6% | -1.0% | · | · | 0.35% | -0.47% | -0.46% | · | -0.73% | |
| ROIC | 0.80% | -3.1% | · | 0.29% | 0.30% | 0.52% | · | 0.42% | 0.23% | -0.71% | · | -0.83% | 0.03% | 0.18% | · | -0.01% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.3 | · | 2.4 | 2.4 | 2.6 | · | 2.3 | 2.4 | 2.6 | · | 2.6 | 2.6 | 2.6 | · | 2.5 | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.9 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.8 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 2.5 | 0.8 | · | 0.7 | 0.5 | 0.6 | · | 0.3 | 0.3 | -0.4 | · | 0.9 | 0.1 | 0.4 | · | -0.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.9 | |
| Receivables Turnover | 3.0 | 2.9 | · | 2.9 | 3.3 | 3.8 | · | 3.5 | 3.8 | 4.0 | · | 3.0 | 2.9 | 3.3 | · | 3.6 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.05 | $84.50 | · | $86.17 | $85.71 | $80.76 | · | $83.76 | $83.43 | · | · | $86.93 | $87.74 | $87.28 | · | $83.94 | |
| Revenue / Share | $22.03 | $21.06 | · | $21.75 | $22.21 | $24.64 | · | $24.11 | $24.45 | $23.39 | · | $22.71 | $22.82 | $23.68 | · | $25.01 | |
| Cash Flow / Share | · | $1.55 | · | · | · | $2.09 | · | · | · | $1.89 | · | · | · | $1.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $12.78 | $12.39 | $10.32 | · | $8.24 | $8.20 | $9.32 | · | $10.29 | |
| EPS (TTM) | $1.19 | $1.86 | · | $-0.31 | $-1.52 | $-3.83 | · | $-4.57 | $-2.92 | $-2.45 | · | $-1.16 | $-2.01 | $-1.91 | · | $-1.56 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.16B | $2.16B | · | $2.32B | $2.37B | $2.42B | · | $2.34B | $2.30B | $2.26B | · | $2.25B | $2.29B | $2.31B | · | $2.04B | |
| Net Income TTM | $30M | $46M | · | $-7M | $-37M | $-94M | · | $-111M | $-71M | $-59M | · | $-31M | $-48M | $-46M | · | $-35M | |
| Market Cap | $3.67B | $3.23B | · | $2.96B | $3.26B | $3.42B | · | $4.46B | $2.90B | $2.61B | · | $2.87B | $4.30B | $3.97B | · | $3.61B | |
| Enterprise Value | · | · | · | · | · | · | · | $5.74B | $4.20B | $3.98B | · | $4.31B | $5.74B | $5.39B | · | $5.02B | |
| P/E | 123.2 | 69.4 | · | -387.0 | -86.9 | -36.3 | · | -39.9 | -40.7 | -43.8 | · | -102.6 | -88.7 | -86.4 | · | -96.5 | |
| P/S | 1.7 | 1.5 | · | 1.3 | 1.4 | 1.4 | · | 1.9 | 1.3 | 1.2 | · | 1.3 | 1.9 | 1.7 | · | 1.8 | |
| P/B | 1.7 | 1.5 | · | 1.4 | 1.5 | 1.7 | · | 2.2 | 1.4 | · | · | 1.4 | 2.0 | 1.9 | · | 1.8 | |
| P / Tangible Book | 36.7 | 117.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 83.0 | · | · | · | 66.6 | · | · | · | 57.1 | · | · | · | 96.2 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 2.5 | 1.8 | 1.8 | · | 1.9 | 2.5 | 2.3 | · | 2.5 | |
| Earnings Yield | 0.81% | 1.4% | · | -0.26% | -1.1% | -2.8% | · | -2.5% | -2.5% | -2.3% | · | -0.97% | -1.1% | -1.2% | · | -1.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Brüt Kâr Marjı % | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% |
| Faaliyet Kâr Marjı % | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% |
| Net Gelir | $732.0K | $-118M | $-30M | $-74M | $103M |
| Seyreltilmiş Hisse Başı Kâr | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.6 | 0.8 | 0.8 | 0.8 | · |
| Cari Oran | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 |
| Cari Oran | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $92M | $125M | $82M | $-152M | $199M |
Kurumsal Sahipler (13F) 306 dosya · $4.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
306
Tutulan Değer
$4.1B
Yeni pozisyonlar
43
Çıkan pozisyonlar
30
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 43 (-6 önceki Ç'ye göre) | 30 (-15 önceki Ç'ye göre) | 118 (+28 önceki Ç'ye göre) | 82 (-14 önceki Ç'ye göre) | -1.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $550.249.759 | 3.753.409 | 13,48% | Hisse senetleri |
| VANGUARD GROUP INC | $387.312.811 | 2.714.746 | 9,49% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $345.607.263 | 2.676.012 | 8,47% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $215.587.468 | 1.470.583 | 5,28% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $190.305.412 | 1.298.127 | 4,66% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $164.666.544 | 1.123.237 | 4,03% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $154.443.449 | 1.053.476 | 3,78% | Hisse senetleri |
| STATE STREET CORP | $150.177.172 | 1.024.369 | 3,68% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $109.340.684 | 739.138 | 2,68% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $101.091.847 | 689.573 | 2,48% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $96.836.293 | 660.423 | 2,37% | Hisse senetleri |
| River Road Asset Management, LLC | $91.814.114 | 626.290 | 2,25% | Hisse senetleri |
| CITADEL ADVISORS LLC | $78.610.585 | 536.225 | 1,93% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $66.157.502 | 451.279 | 1,62% | Hisse senetleri |
| JPMORGAN CHASE & CO | $65.312.452 | 440.468 | 1,60% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $61.182.264 | 417.342 | 1,50% | Hisse senetleri |
| MORGAN STANLEY | $54.620.878 | 372.583 | 1,34% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $54.059.336 | 368.754 | 1,32% | Hisse senetleri |
| TORONTO DOMINION BANK | $52.486.172 | 358.023 | 1,29% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $48.532.223 | 331.052 | 1,19% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $48.227.000 | 328.969 | 1,18% | Hisse senetleri |
| REINHART PARTNERS, LLC. | $46.147.615 | 314.768 | 1,13% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $43.614.563 | 297.505 | 1,07% | Hisse senetleri |
| NORTHERN TRUST CORP | $43.361.202 | 295.779 | 1,06% | Hisse senetleri |
| FMR LLC | $41.516.428 | 283.195 | 1,02% | Hisse senetleri |
| FEDERATED HERMES, INC. | $35.688.010 | 243.438 | 0,87% | Hisse senetleri |
| BROWN ADVISORY INC | $34.772.232 | 237.191 | 0,85% | Hisse senetleri |
| OBERWEIS ASSET MANAGEMENT INC/ | $34.751.530 | 237.050 | 0,85% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $32.552.823 | 222.052 | 0,80% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $31.094.299 | 212.103 | 0,76% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $29.850.399 | 203.618 | 0,73% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $28.651.797 | 195.442 | 0,70% | Hisse senetleri |
| Bank of New York Mellon Corp | $26.966.404 | 183.945 | 0,66% | Hisse senetleri |
| NORGES BANK | $26.055.658 | 177.733 | 0,64% | Hisse senetleri |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $25.241.735 | 172.181 | 0,62% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $24.343.810 | 166.056 | 0,60% | Hisse senetleri |
| Point72 Asset Management, L.P. | $24.257.755 | 165.469 | 0,59% | Hisse senetleri |
| Woodline Partners LP | $24.087.113 | 164.305 | 0,59% | Hisse senetleri |
| Quantinno Capital Management LP | $23.256.917 | 158.642 | 0,57% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $21.841.347 | 148.986 | 0,54% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $21.327.368 | 145.480 | 0,52% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $18.959.631 | 129.329 | 0,46% | Hisse senetleri |
| Defilade Capital Management, L.P. | $15.495.620 | 105.700 | 0,38% | Hisse senetleri |
| UBS Group AG | $14.515.160 | 99.012 | 0,36% | Hisse senetleri |
| Nuveen, LLC | $14.023.903 | 95.661 | 0,34% | Hisse senetleri |
| Invesco Ltd. | $13.846.957 | 94.454 | 0,34% | Hisse senetleri |
| GLENMEDE TRUST CO NA | $13.638.051 | 93.029 | 0,33% | Hisse senetleri |
| Public Sector Pension Investment Board | $12.585.170 | 85.847 | 0,31% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $10.257.222 | 79.421 | 0,25% | Hisse senetleri |
| RHUMBLINE ADVISERS | $9.138.587 | 62.337 | 0,22% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Smiths Group plc, Smiths Group International Holdings Limited ×3 başvurular | 18 Temmuz 2024 | · | İlk başvuru | · | SEC |
| Pfizer Inc. (“Pfizer”) IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. (the “Shareholder”) IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC (“PPL”) IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC (“PML” and together with PPL, the “General Partners”) IRS Identification Nos. of above persons (entities only) ×2 başvurular | 16 Kasım 2018 | · | İlk başvuru | · | SEC |
| Pfizer Inc. ("Pfizer") IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC IRS Identification Nos. of above persons (entities only) | 13 Şubat 2017 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi | 12 Kasım 2002 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 28 içeriden öğrenenler · 12 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Vivek Jain | Chairman and CEO | 15 Mart 2026 M | 126.833 | 0 | 0 | $0 |
| Brian Michael Bonnell | Chief Financial Officer | 01 Eylül 2026 S | 56.062 | 0 | 5 | $-2.724.787 |
| Francis J Obrien | Chief Financial Officer | 15 Şubat 2008 P | 8.046 | 0 | 0 | $0 |
| Christian B. Voigtlander | Chief Operating Officer | 11 Ağustos 2026 S | 37.377 | 0 | 1 | $-1.633.382 |
| Virginia Ruth Sanzone | VP, General Counsel | 03 Eylül 2026 S | 14.604 | 0 | 6 | $-1.255.170 |
| Daniel Woolson | VP, GM-Infusion Capital | 13 Ağustos 2026 S | 17.062 | 0 | 3 | $-1.704.305 |
| Ben Sousa | Chief Information Officer | 12 Ağustos 2026 S | 3.076 | 0 | 1 | $-401.220 |
| Kevin J Mcgrody | Chief Accounting Officer | 06 Mart 2022 M | 4.846 | 0 | 0 | $0 |
| Thomas D Mccall | Vice President and Gen'l Mgr. | 17 Ocak 2020 M | 7.841 | 0 | 0 | $0 |
| Burcar Alison Brummett | Vice President and Gen'l Mgr. | 27 Mart 2019 M | 6.794 | 0 | 0 | $0 |
| Steven Riggs | VP Operations | 11 Şubat 2018 M | 3.127 | 0 | 0 | $0 |
| Richard A Costello | Vice President Sales | 25 Şubat 2014 X | 285 | 0 | 0 | $0 |
| Laurie Hernandez | Yönetim kurulu üyesi | 13 Mayıs 2026 A | 4.862 | 0 | 0 | $0 |
| David C. Greenberg | Yönetim kurulu üyesi | 13 Mayıs 2026 A | 9.214 | 0 | 1 | $-297.934 |
| Donald Abbey | Yönetim kurulu üyesi | 13 Mayıs 2026 A | 6.004 | 0 | 0 | $0 |
| Kolleen T Kennedy | Yönetim kurulu üyesi | 13 Mayıs 2026 A | 4.539 | 0 | 0 | $0 |
| George A Lopez | Yönetim kurulu üyesi | 14 Mart 2024 S | 877.343 | 0 | 0 | $0 |
| Robert S Swinney | Yönetim kurulu üyesi | 15 Eylül 2021 S | 20.816 | 0 | 0 | $0 |
| Joseph R Saucedo | Yönetim kurulu üyesi | 14 Mayıs 2018 S | 0 | 0 | 0 | $0 |
| Richard Sherman MD | Yönetim kurulu üyesi | 16 Mayıs 2017 M | 69.942 | 0 | 0 | $0 |
| Jack Brown | Yönetim kurulu üyesi | 05 Ekim 2015 X | 19.862 | 0 | 0 | $0 |
| John J Connors | Yönetim kurulu üyesi | 09 Haziran 2015 M | 2.456 | 0 | 0 | $0 |
| Michael T Kovalchik | Yönetim kurulu üyesi | 09 Mayıs 2014 M | 4.602 | 0 | 0 | $0 |
| Elisha W Finney | · | 11 Ağustos 2026 S | 4.871 | 0 | 2 | $-249.417 |
| David F Hoffmeister | · | 13 Mayıs 2026 A | 6.004 | 0 | 0 | $0 |
| Smiths Group International Holdings Ltd | · | 29 Şubat 2024 S | 1.670.000 | 0 | 0 | $0 |
| SMITHS GROUP PLC | · | 29 Şubat 2024 S | 1.670.000 | 0 | 0 | $0 |
| Scott E Lamb | · | 14 Şubat 2020 M | 16.274 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 52 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 2,16% | 24.055 SH | 01 Ekim 2026 | Günlük |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 690 SH | 01 Ekim 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,28% | 4.061 SH | 01 Ekim 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 8.560 NS | 31 Temmuz 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,24% | 116.117 NS | 31 Temmuz 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,23% | 21.594 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,22% | 36.321 SH | 01 Ekim 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,20% | 87.418 SH | 19 Ağustos 2026 | Günlük |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,20% | 27.578 SH | 19 Ağustos 2026 | Günlük |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,19% | 14.279 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 6.091 NS | 31 Temmuz 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,15% | 11.901 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,14% | 734 NS | 31 Temmuz 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,14% | 16.990 SH | 01 Ekim 2026 | Günlük |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,14% | 1.600 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,13% | 11.831 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,13% | 632.805 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 142.142 SH | 19 Ağustos 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,10% | 85.853 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,09% | 77.820 NS | 31 Temmuz 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,08% | 364.019 SH | 19 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,07% | 11.599 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 11.256 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 71.375 SH | 19 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,05% | 2.813 SH | 11 Eylül 2026 | Günlük |
| SMDX · Tidal Trust III | 0,04% | 311 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 286.547 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,04% | 573.524 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,03% | 1.443 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,03% | 1.111 NS | 31 Temmuz 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,03% | 278 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 58.989 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2.490 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 3.385 NS | 31 Temmuz 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,02% | 15.263 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 1.530 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 792.153 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 5.438 SH | 19 Ağustos 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,01% | 6.148 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 7.354 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 32.068 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 6.145 SH | 11 Eylül 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 19.221 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.073 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 1.525.334 SH | 10 Eylül 2026 | Günlük |
| IJT · iShares Trust | · | 113.714 SH | 09 Eylül 2026 | Günlük |
| IJS · iShares Trust | · | 115.864 SH | 08 Eylül 2026 | Günlük |
| IWN · iShares Trust | · | 232.180 SH | 11 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 3.458 SH | 31 Ağustos 2026 | Günlük |
| SVAL · iShares Trust | · | 5.101 SH | 03 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 1.008 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 3.047 SH | 11 Eylül 2026 | Günlük |
ICUI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 13 analist
AL
Medyan hedef
$192.50
+20,8%
5 38,5%
Güçlü Al
7 53,8%
Al
1 7,7%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
8 analist · 2026-10-01Ortalama hedef $193.38 +21,3%
← Tüm hedeflerin altında
Mevcut fiyat $159.38
Düşük$178.00
Ortalama$193.38
Yüksek$210.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026